NCT01286649View on ClinicalTrials.gov

Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

February 23, 2017

Conditions
Androgenetic Alopecia
Interventions
OTHER

Human autologous hair follicle cells

Human autologous hair follicle cells suspended in cell medium

OTHER

Cell medium

Cell medium

Trial Locations (1)

0112

Scientific Research Institute for Skin and Venereal Diseases, Department of Dermatology, Tbilisi

Sponsors
All Listed Sponsors
collaborator

Pharmalog Institut für klinische Forschung GmbH (PHARMALOG Institute for Clinical Research)

UNKNOWN

collaborator

PRA Health Sciences

INDUSTRY

collaborator

Innovacell Biotechnologie AG

INDUSTRY

collaborator

DatInf (Germany)

UNKNOWN

collaborator

The Hair and Skin Research and Treatment Center

UNKNOWN

lead

TrichoScience Innovations, Inc.

INDUSTRY